Dr. Kai-Fu Lee (Sinovation Ventures and 01.AI) – Making AI Work: A Roadmap to Unleash the Power of GenAI and Build a Healthier Ecosystem

Date: Wednesday, October 9th, 2024

Time: 2-3 PM

Location: 430 Soda Hall (Wozniak Lounge)

Abstract: Generative AI is driving one of the most powerful productivity revolutions in human history, with its rapidly advancing intelligence. However, significant challenges remain before the full potential of large language models (LLMs) can be realized, and a sustainable ecosystem established. Join Dr. Kai-Fu Lee, globally renowned AI expert, Founder & CEO of 01.AI, founding president of Google China, and author of AI 2041 and the bestseller AI Superpowers, as he discusses the future roadmap of this revolution. In this talk, Dr. Lee will share his insights, predictions on key factors shaping this revolution, and his exciting journey in building an LLM venture to harness the full power of AI.

Bio: Dr. Kai-Fu Lee is the Chairman of Sinovation Ventures and CEO of 01.AI. Sinovation Ventures, managing US$3 billion dual currency investment funds, is a leading venture capital firm focusing on developing the next-generation deep tech companies. With a unique “VC+AI” model, Dr. Lee also leads the venture-building efforts of seven AI startups including the latest 01.AI, a new company capturing the LLM-driven AI 2.0 opportunity. Before founding Sinovation, Dr. Lee was the President of Google China, and a senior executive at Microsoft, SGI, and Apple. Dr. Lee received his Bachelor’s degree in Computer Science from Columbia University, a Ph.D. from Carnegie Mellon University, and Honorary Doctorate Degrees from both Carnegie Mellon and the City University of Hong Kong. He co-chaired the Artificial Intelligence Council for the World Economic Forum Center for the Fourth Industrial Revolution and is highly recognized as “TIME100 AI” Top 25 AI Leaders in the World, 100 Most Influential People in the World by TIME Magazine in 2013, WIRED 25 Icons, and followed by over 50 million audiences on social media.